Hematological Malignancies Clinical Trials in Barcelona

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Durvalumab and Tremelimumab for Pediatric Malignancies
Recruiting
  • Pediatric Cancer
  • +2 more
  • Durvalumab / Tremelimumab Combination Therapy
  • Baltimore, Maryland
  • +22 more
2022-03-14
Mar 14, 2022
J
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Hematological Malignancies
  • Duarte, California
  • +12 more
2022-03-24
Mar 24, 2022
J
A Study of Teclistamab, in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +73 more
2022-03-24
Mar 24, 2022
J
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +77 more
2022-03-24
Mar 24, 2022
G
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard Umbilical Cord Blood in Patients With Leukemia, Lymphoma, and Myelodysplastic Syndrome (MDS)
Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
2021-01-07
Jan 7, 2021
G
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM - 2018
Completed
Has Results
  • Hematological Malignancies
  • +3 more
  • Los Angeles, California
  • +14 more
2020-10-01
Oct 1, 2020
H
Intrabone Cord Blood Transplantation
Unknown status
  • Hematological Malignancies
  • Intrabone administration of umbilical cord blood
  • Barcelona, Spain
    BMT Unit Hematology Department Hospital Clinic
2009-02-05
Feb 5, 2009